GlassScriptPhysician profile
Sarah Rizer Murrell
NPI 1306500947
$2,055.74
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $985 · 2023: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $483.24 | 2022-2023 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $260.32 | 2022-2023 | Dupixent |
| Glaxosmithkline, LLC. | $241.67 | 2022-2023 | Trelegy Ellipta, Nucala |
| Csl Behring | $193.70 | 2022-2023 | Haegarda |
| Takeda Pharmaceuticals U.S.A., INC. | $158.57 | 2023 | Takhzyro, Cuvitru |
| Genzyme Corporation | $95.64 | 2022-2023 | |
| Pfizer INC. | $82.94 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $76.91 | 2022-2023 | |
| Genentech USA, INC. | $66.81 | 2022 | |
| Grifols USA, LLC | $59.95 | 2022-2023 | Xembify |
| Optinose US, INC. | $58.13 | 2022-2023 | |
| Kaleo, INC. | $53.00 | 2023 | Auvi-Q |
| Pharming Healthcare, INC. | $49.31 | 2023 | Ruconest |
| Aimmune Therapeutics, INC. | $39.48 | 2022 | |
| Octapharma USA, INC. | $31.41 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covis Pharma Gmbh | $26.50 | 2022 | |
| Leo Pharma INC. | $22.05 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $19.55 | 2022 | |
| Merck Sharp & Dohme LLC | $19.51 | 2023 | |
| Blueprint Medicines Corporation | $17.05 | 2023 | Ayvakit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Murrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.